SCHEMBL23923250

SCHEMBL23923250

CCCC(C(=O)O)c1cccnc1Cl

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
FAAH O00519 5/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
POLB P06746 1/20 0.38
FFAR2 O15552 1/20 0.37
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
RAB9A P51151 1/20 0.37
MME P08473 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20534707 0.78 MEN1 (0.48) CYP3A4ALDH1A1MEN1KMT2A
SCHEMBL27714552 0.76 SMN1; SMN2 (0.43) SMN1; SMN2LMNAFAAHCYP1A2CYP2C9
SCHEMBL2561237 0.76 SMN1; SMN2 (0.50) SMN1; SMN2LMNAFAAHPOLBCNR1
SCHEMBL30752809 0.74 FAAH (0.36) SMN1; SMN2LMNAFAAHCYP2C19CYP2D6
SCHEMBL6664414 0.73 CYP1A2 (0.53) SMN1; SMN2LMNACYP1A2CYP2C9CYP2C19
SCHEMBL3635902 0.72 SMN1; SMN2 (0.50) SMN1; SMN2LMNAFAAHCYP1A2CYP2C9
SCHEMBL8015528 0.72 TSHR (0.48) LMNACYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL22383428 0.72 TSHR (0.48) LMNACYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL6262528 0.72 ACP3 (0.41) CYP1A2CYP2C9CYP2C19CYP3A4CYP2D6
SCHEMBL27897428 0.72 SMN1; SMN2 (0.46) SMN1; SMN2LMNAFAAHCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3896068-A1 S1P3 ANTAGONISTS Teva Pharmaceutical Industries Limited (IL) 2021-10-20 EP disclosed